Investor Relations

Press Room

Search
press release List
No Subjects Date hit
30 Yungjin Pharm had achieved $92.3m for the first half year of 2019, and expecting $200m for the year achievement 2019-08-27 1124
29 Yungjin Pharm selected as '2019 Excellent Labor-Management Culture Company' 2019-08-13 1049
28 Company presentation in BIO International Convention 2019 at Philadelphia, US 2019-06-04 1350
27 Yungjin Pharm announced a new targeted anti-cancer drug at AACR 2019 2019-04-09 1744
26 Yungjin's new anti-cancer drug selected as a project for KDDF 2019-03-07 1374
25 Yungjin Pharm has obtained the 'ISO 37001', the international standard for anti-corruption management system 2019-01-07 1490
24 Starting a Co-Development Partnership with GENOME & COMPANY 2018-10-01 1500
23 Yungjin Pharm held a groundbreaking ceremony for the construction of industrial complex 2018-09-06 1317
22 Yungjin Pharm and APIC(Japan) Contracted a Supply Agreement of Loxoprofen Sodium Hydrate to Japan 2018-08-01 1771
21 Lee Chae Joon appointed as the new CEO of Yungjin Pharm 2018-04-17 1730
Previous Page1234next page

Quick menu